Translational Science

Welcome back to our interview series with Jon Thomas, President and CEO of the California Institute for Regenerative Medicine: CIRM.

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy

The contribution of macaques to advancing human understanding of flu-like viruses, including H5N1, cannot be overstated.

Check out our video interview with Debra Weiss from the Bill & Melinda Gates Medical Research Institute.

Contribute to our special feature celebrating the future of pharma.

Developing modified release formulations can be complex – but a translational pharmaceutics approach can smooth the path

Biological engineering project featuring GSK seeks to use food by-products to create antimicrobials.

Testing directly on a diseased human cell is more efficient and more accurate, but ambition is lacking

We ask an expert from Elsevier about the future of digital tech in drug discovery.

The case of Kathleen Folbigg shows how far the field has come, but there are still no medical interventions for sudden infant death syndrome.